Pfizer denies ties with Sprinklr on Kerala Covid-19 data deal
21-April-2020

Global pharmaceutical major Pfizer on Tuesday denied that it has partnered with Sprinklr to support the provision of any Covid-19 patient information from India.
The clarification came after Pfizer was dragged into a controversy surrounding the Kerala government's deal with the US-based tech firm Sprinklr to handle data compiled from people who are quarantined due to the Covid-19 crisis.
The Kerala government has faced criticism for allegedly compromising with the privacy of the quarantined people.
Following news surfacing about the relations of Pfizer with Sprinklr, a Congress leader, here on Monday, had demanded a CBI probe into the deal.
"Pfizer has reviewed news reports on access to Covid-19 patient data appearing in certain sections of the media and has found these to be entirely baseless," the company said in a statement.
"We have not partnered with Sprinklr to support the provision of any Covid-19 patient information from India. We use Sprinklr's platform to manage content on our social media channels," the company said.
Sprinklr is a leading customer and citizen experience management (CXM) platform that helps organisations reach, engage and listen to customers across social channels, messaging channels, forums, blogs and review sites.-IANS
Larry Ellison Overtakes Elon Musk as World’s Richest Person After Oracle Stock Surge
Trump's aide Charlie Kirk Shot Dead at University Event In Utah
Nepal Shuts Pashupatinath Temple as Violent Youth Protests Escalate
Gen Z Protests Push Nepal to Restore Social Media Access After Youth-Led Unrest
Trump Softens Tone on India: “I’ll Always Be Friends With Modi” as Trade Row Deepens